Modulation of Lymphocyte Function for Cancer Therapy: A Phase II Trial of Tremelimumab in Advanced Gastric and Esophageal Adenocarcinoma

被引：0
|
作者：
Ralph, Christy [1 ,2 ]
Elkord, Eyad [1 ]
Thistlethwaite, Fiona C. [1 ]
Burt, Debbie J. [1 ]
O'Dwyer, Jackie [1 ]
Stern, Peter L. [2 ]
Hawkins, Robert F.
机构：
[1] Christie NHS Fdn Trust, Paterson Inst Canc Res, Manchester, Lancs, England
[2] Univ Manchester, Paterson Inst Canc Res, Manchester, Lancs, England
来源：
JOURNAL OF IMMUNOTHERAPY | 2009年 / 32卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：960 / 961
页数：2
相关论文
共 50 条
  • [1] Modulation of Lymphocyte Regulation for Cancer Therapy: A Phase II Trial of Tremelimumab in Advanced Gastric and Esophageal Adenocarcinoma
    Ralph, Christy
    Elkord, Eyad
    Burt, Deborah J.
    O'Dwyer, Jackie F.
    Austin, Eric B.
    Stern, Peter L.
    Hawkins, Robert E.
    Thistlethwaite, Fiona C.
    CLINICAL CANCER RESEARCH, 2010, 16 (05) : 1662 - 1672
  • [2] A Phase II Trial of Irinotecan in Patients with Previously Untreated Advanced Esophageal and Gastric Adenocarcinoma
    Peter C. Enzinger
    Matthew H. Kulke
    Jeffrey W. Clark
    David P. Ryan
    Haesook Kim
    Craig C. Earle
    Michele M. Vincitore
    Ann L. Michelini
    Robert J. Mayer
    Charles S. Fuchs
    Digestive Diseases and Sciences, 2005, 50 : 2218 - 2223
  • [3] A phase II trial of irinotecan in patients with previously untreated advanced esophageal and gastric adenocarcinoma
    Enzinger, PC
    Kulke, MH
    Clark, JW
    Ryan, DP
    Kim, H
    Earle, CC
    Vincitore, MM
    Michelini, AL
    Mayer, RJ
    Fuchs, CS
    DIGESTIVE DISEASES AND SCIENCES, 2005, 50 (12) : 2218 - 2223
  • [4] Phase II trial of palbociclib in patients with advanced esophageal or gastric cancer.
    Karasic, Thomas Benjamin
    O'Hara, Mark H.
    Teitelbaum, Ursina R.
    Damjanov, Nevena
    Giantonio, Bruce J.
    d'Entremont, Tracy S.
    Gallagher, Maryann
    Zhang, Paul J.
    O'Dwyer, Peter J.
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (04)
  • [5] A multicenter phase II trial of single-agent cetuximab in advanced esophageal and gastric adenocarcinoma
    Chan, J. A.
    Blaszkowsky, L. S.
    Enzinger, P. C.
    Ryan, D. P.
    Abrams, T. A.
    Zhu, A. X.
    Temel, J. S.
    Schrag, D.
    Bhargava, P.
    Meyerhardt, J. A.
    Wolpin, B. M.
    Fidias, P.
    Zheng, H.
    Florio, S.
    Regan, E.
    Fuchs, C. S.
    ANNALS OF ONCOLOGY, 2011, 22 (06) : 1367 - 1373
  • [6] A prospective phase II clinical trial of total neoadjuvant therapy for locally advanced gastric cancer and gastroesophageal junction adenocarcinoma
    Shi, Jin-Ming
    Li, Ning
    Jiang, Li-Ming
    Yang, Lin
    Wang, Shu-Lian
    Song, Yong-Wen
    Liu, Yue-Ping
    Fang, Hui
    Lu, Ning-Ning
    Qi, Shu-Nan
    Chen, Bo
    Li, Ye-Xiong
    Zhao, Dong-Bing
    Tang, Yuan
    Jin, Jing
    SCIENTIFIC REPORTS, 2024, 14 (01)
  • [7] Phase II trial of docetaxel and oxaliplatin in patients with advanced gastric cancer and/or adenocarcinoma of the gastroesophageal junction
    Richards, D.
    McCollum, D.
    Wilfong, L.
    Sborov, M.
    Boehm, K. A.
    Zhan, F.
    Asmar, L.
    ANNALS OF ONCOLOGY, 2008, 19 (01) : 104 - 108
  • [8] Palliative Radiation Therapy for Symptomatic Locally Advanced Gastric Cancer: A Phase II Trial
    Tey, J.
    Lee, K. M.
    Leong, C. N.
    Zheng, H.
    Koh, W. Y.
    Lim, K. H. C.
    Soon, Y. Y.
    Tham, I.
    Lu, J. J.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2015, 93 (03): : E134 - E135
  • [9] Nivolumab plus anlotinib hydrochloride in advanced gastric adenocarcinoma and esophageal squamous cell carcinoma: the phase II OASIS trial
    Wu, Jing
    Zhang, Shilong
    Yu, Shan
    An, Guo
    Wang, Yi
    Yu, Yiyi
    Liang, Li
    Wang, Yan
    Xu, Xiaojing
    Xiong, YanShi
    Shao, Di
    Shi, Zhun
    Li, Nannan
    Wang, Jingyuan
    Jin, Dawei
    Liu, Tianshu
    Cui, Yuehong
    NATURE COMMUNICATIONS, 2024, 15 (01)
  • [10] MITOXANTRONE THERAPY OF ADVANCED ADENOCARCINOMA OF THE ENDOMETRIUM - A PHASE-II TRIAL
    RUNGE, HM
    MEERPOHL, HG
    PFLEIDERER, A
    ONKOLOGIE, 1989, 12 (02): : 102 - 103
12345